Conductive polymeric coating with optional biobeneficial topcoat for a medical lead
First Claim
Patent Images
1. A cardiac lead comprising:
- a lead body extending from a proximal end portion to a distal end portion;
a cardiac electrode disposed along the lead body; and
a coating in contact with at least a portion of the electrode, the coating including a matrix polymer layer and a topcoat layer over the matrix layer,where in the matrix polymer layer comprises at least one of sulfonated polytetrafluorethylene, poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) or polypyrrole polystyrene sulfonate and the topcoat layer comprises phosphorylcholine (PC), polyvinylpyrrolidone (PVP), poly(vinyl alcohol) (PVA), hyaluronic acid (HA), polyactive or a combination thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
A cardiac lead comprising a lead body extending from a proximal end portion to a distal end portion; a cardiac electrode disposed along the lead body; and a coating associated with at least a portion of the electrode, the coating comprises a conductive polymer.
80 Citations
14 Claims
-
1. A cardiac lead comprising:
-
a lead body extending from a proximal end portion to a distal end portion; a cardiac electrode disposed along the lead body; and a coating in contact with at least a portion of the electrode, the coating including a matrix polymer layer and a topcoat layer over the matrix layer, where in the matrix polymer layer comprises at least one of sulfonated polytetrafluorethylene, poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) or polypyrrole polystyrene sulfonate and the topcoat layer comprises phosphorylcholine (PC), polyvinylpyrrolidone (PVP), poly(vinyl alcohol) (PVA), hyaluronic acid (HA), polyactive or a combination thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A method comprising:
-
covering a portion of a cardiac electrode with a coating, wherein the coating comprises a matrix polymer layer and a topcoat layer over the matrix layer, wherein the matrix polymer layer comprises at least one conductive matrix polymer comprising sulfonated polytetrafluorethylene, poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate), polypyrrole polystyrene sulfonate, or a combination thereof and the topcoat layer comprises phosphorylcholine (PC), polyvinylpyrrolidone (PVP), poly(vinyl alcohol) (PVA), hyaluronic acid (HA), polyactive or a combination thereof; and delivering the cardiac electrode to a site of implantation. - View Dependent Claims (11, 12, 13, 14)
-
Specification